Prajwal Boddu
Overview
Explore the profile of Prajwal Boddu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
518
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olazabal-Herrero A, He B, Kwon Y, Gupta A, Dutta A, Huang Y, et al.
Cell Rep
. 2024 Jan;
43(1):113610.
PMID: 38165804
Fanconi anemia (FA) is characterized by congenital abnormalities, bone marrow failure, and cancer susceptibility. The central FA protein complex FANCI/FANCD2 (ID2) is activated by monoubiquitination and recruits DNA repair proteins...
2.
Kim S, Sheshadri A, Shannon V, Kontoyiannis D, Kantarjian H, Garcia-Manero G, et al.
Front Immunol
. 2021 Feb;
11:590494.
PMID: 33552049
Patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) treated with immune checkpoint inhibitors (ICIs) are at risk of pneumonitis as well as pneumonia (combined henceforth as ICI-related pulmonary...
3.
Messer A, Brown A, Pacha O, Boddu P, Geppner A, Kadia T, et al.
JAAD Case Rep
. 2019 Nov;
5(11):979-981.
PMID: 31709290
No abstract available.
4.
Boddu P, Jain P, Borthakur G, Verstovsek S, Garcia-Manero G, Daver N, et al.
Leuk Lymphoma
. 2019 May;
60(13):3172-3180.
PMID: 31125272
Considering the risk of arterio-thrombotic adverse events (AEs), ponatinib trials in previously untreated chronic myeloid leukemia chronic phase (CML-CP) were terminated. We conducted a retrospective CML-CP outcome study of patients...
5.
Boddu P, Carter B, Verstovsek S, Pemmaraju N
Br J Haematol
. 2019 Mar;
185(2):219-231.
PMID: 30836448
Evasion of apoptosis has been identified as one of the essential hallmarks of cancer. Inhibitor of apoptosis proteins (IAPs) are implicated in a host of myeloid malignancies, providing the rationale...
6.
Boddu P, Gibbons J, Burger J, Sivina M, Thakral B, Kanagal-Shamanna R, et al.
Leuk Lymphoma
. 2019 Jan;
60(6):1568-1571.
PMID: 30632839
No abstract available.
7.
Boddu P, Thakral B, Alhuraiji A, Pemmaraju N, Kadia T, Ohanian M, et al.
J Clin Pathol
. 2018 Nov;
72(3):251-257.
PMID: 30467242
T-lymphoblastic lymphoma and thymoma are distinct primary mediastinal neoplasms that can have similar clinical presentations and overlapping histological features. Microscopic distinction is occasionally difficult because the immature lymphocytes associated with...
8.
Boddu P, Borthakur G, Koneru M, Huang X, Naqvi K, Wierda W, et al.
Front Oncol
. 2018 Oct;
8:369.
PMID: 30319961
The CXCR4/SDF-1α axis plays a vital role in the retention of stem cells within the bone marrow and downstream activation of cell survival signaling pathways. LY2510924, a second generation CXCR4,...
9.
Boddu P, Chihara D, Masarova L, Pemmaraju N, Patel K, Verstovsek S
Ann Hematol
. 2018 Jun;
97(11):2071-2080.
PMID: 29951914
Myeloproliferative neoplasms (MPNs) are clonal disorders characterized by proliferation of one or more elements of the myeloid lineage. Key genetic aberrations include the BCR-ABL1 gene rearrangement in Philadelphia chromosome-positive chronic...
10.
Won A, Boddu P, Otun A, Aponte-Wesson R, Chambers M
Oral Surg Oral Med Oral Pathol Oral Radiol
. 2018 Jun;
126(4):e208-e211.
PMID: 29941400
This report describes a case of osteonecrosis of the jaw developing after a routine dental extraction in a patient being treated with dasatinib, a tyrosine kinase inhibitor, for chronic myelogenous...